Hims & Hers Health Inc (NY: HIMS )
20.32
+0.90
(+4.63%)
Streaming Delayed Price
Updated: 12:15 PM EDT, Jul 22, 2024
Add to My Watchlist
All News about Hims & Hers Health Inc
![](https://mms.businesswire.com/media/20230613549635/en/1817431/22/Hers_Hair_Blends_2.jpg)
![](https://mms.businesswire.com/media/20230531005388/en/1806648/22/Hims_HardMints_PR_3000x2000_Image6.jpg)
![](/next-assets/images/schema-image-default.png)
6 Analysts Have This to Say About Hims & Hers Health
May 30, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Analyst Expectations for Hims & Hers Health's Future
May 30, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/733428/male-scientist-looking-through-microscope.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/ep_us_feature_image_3612.jpeg?width=1200&height=800&fit=crop)
A Preview Of Hims & Hers Health's Earnings
May 05, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/728761/vitamins-holistic-medicine-health.jpg)
![](https://www.marketbeat.com/logos/articles/med_20230517114525_how-to-invest-in-telehealth-and-telemedicine-stock.jpg)
![](https://g.foolcdn.com/editorial/images/731765/examining-some-beauty-products-in-a-salon.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/04/25/first_republic_bank_-_logo.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
8 Analysts Have This to Say About Hims & Hers Health
April 11, 2023
Via Benzinga
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Hims & Hers Certified as a ‘Great Place to Work’
March 23, 2023
Via Business Wire
![](/next-assets/images/schema-image-default.png)
Hims & Hers Health's Return On Capital Employed Overview
March 02, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
7 Analysts Have This to Say About Hims & Hers Health
March 01, 2023
Via Benzinga
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
![](https://mms.businesswire.com/media/20230315005632/en/1739463/5/Hims_Dandruff_2.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20230314005429/en/1737530/22/HH_Daniel_Z._Lieberman.jpg)
![](https://mms.businesswire.com/media/20230310005431/en/1736083/5/Hims%26Hers-Lockup-Final.jpg)
![](https://g.foolcdn.com/editorial/images/723701/telehealth-doctor-prescribing-pills.jpg)
![](https://g.foolcdn.com/editorial/images/722910/wooden-cube-blocks.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/02/28/image31.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/02/28/image29_0.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.